Sprint Bioscience is looking to replace Decipher as a partner for VPS34 as soon as the project is ha...
Q-linea finishes 2023 on a positive note as the company has placed the first two US ASTar systems.
Redeye is encouraged to see RemaSawco winning another major order amounting to SEK21m.
Last week, Netmore press released that it has signed a non-binding letter of intent (LOI) to acquire...
Redeye is positive towards today’s news that Saniona has selected SAN2355 as the first clinical cand...
Redeye comments on the news that IRLAB has entered into a loan agreement with Formue Nord.
This morning Strax announced it will sell Urbanista to its debt holders P Capital Partners AB (PCP) ...
Redeye revises its fair value range upwards after correcting a previous error about the treatment of...
Watch the replay of Egetis Therapeutics' capital markets day.
We cut '24e-'25e adj. EBIT by 63-36%EBIT recovery delayed into 2024'24e-'25e EV/EBIT 30x-10xTough bu...
Redeye has made some adjustments to our near-term forecasts following the announcement of system del...
Taaleri announced today the second close of its new flagship fund Solar Wind III with EUR 430m of co...
Målrevidering reflekterar primärt förväntningar på lägre förvärvstillväxt VO2 har meddelat att bolag...
RanLOS AB (publ) (”RanLOS” eller ”bolaget”) meddelade den 20 december en årlig statusuppdatering öve...
Redeye comments on ACapital Cara HoldCo AS's demand for an extraordinary general meeting.
Binero proposed a merger with Infrateq in an all-stock deal.
Redeye comments on the news that IRL757 is phase I ready and that IRLAB receives financing from the ...
Equity analyst Markus Almerud discusses Maha Energy after the acquisition of an exclusivity to part ...
Redeye is impressed by the speed at which Telenor/DNA placed their first order.
Substansrabatten ligger långt över det historiska genomsnittet.
